Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain
- PMID:23994452
- DOI: 10.1016/j.neuroimage.2013.08.035
Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain
Abstract
Only recently the first successful serotonin 2A (5-HT2A) receptor agonist PET radioligands have been described, with [(11)C]Cimbi-36 reported as the most promising in the pig brain so far. Agonist radioligands may target specifically the G protein-coupled state of the receptors and thereby provide a more meaningful assessment of available receptors than antagonist radioligands. In the current study we characterized [(11)C]Cimbi-36 receptor binding in the primate brain. On five experimental days, a total of 14 PET measurements were conducted in three female rhesus monkeys. On each day, PET measurements were conducted after intravenous injection of [(11)C]Cimbi-36 during baseline conditions and after intravenous infusion of the 5-HT2 receptor antagonist ketanserin (n=3) or the 5-HT2C receptor antagonist SB 242084 (n=2). On four of the experimental days an additional baseline PET measurement was conducted after injection of [(11)C]MDL 100907. All PET measurements were performed for 2h in a HRRT PET system and arterial blood was obtained for measurement of the [(11)C]Cimbi-36 input function. Quantification of [(11)C]Cimbi-36 receptor binding was performed using kinetic and graphical analysis. After injection of [(11)C]Cimbi-36 the regional distribution of radioactivity in brain was in accordance with the known 5-HT2 receptor distribution. The two-tissue compartment model was superior for the description of the time-radioactivity curves of all examined brain regions. BPND values obtained with reference tissue models correlated with corresponding values obtained with kinetic modeling. Administration of ketanserin decreased the binding in all brain regions but did not affect the cerebellar distribution volume. The BPND of [(11)C]Cimbi-36 was 56±8% of [(11)C]MDL 100907 across cortical regions, but higher in other brain regions including choroid plexus. After administration of SB 242084, [(11)C]Cimbi-36 binding was nearly completely inhibited in the choroid plexus, partly reduced in several subcortical regions (e.g. hippocampus), but not affected in the cortical regions. In conclusion, the receptor binding of [(11)C]Cimbi-36 can be quantified using kinetic modeling and the cerebellum was found to be a suitable reference region. The difference between [(11)C]Cimbi-36 and [(11)C]MDL 100907 binding in the choroid plexus is related to 5-HT2C receptor binding of [(11)C]Cimbi-36. [(11)C]Cimbi-36 is the first agonist radioligand suitable for examination of 5-HT2A receptors in the cortical regions and of 5-HT2C receptors in the choroid plexus of the primate brain.
Keywords: 5-HT(2A); 5-HT(2C); Agonist; Monkey; Serotonin receptors; [(11)C]Cimbi-36.
© 2013.
Similar articles
- Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.Ettrup A, Svarer C, McMahon B, da Cunha-Bang S, Lehel S, Møller K, Dyssegaard A, Ganz M, Beliveau V, Jørgensen LM, Gillings N, Knudsen GM.Ettrup A, et al.Neuroimage. 2016 Apr 15;130:167-174. doi: 10.1016/j.neuroimage.2016.02.001. Epub 2016 Feb 11.Neuroimage. 2016.PMID:26876490
- Serotonin 2A receptor agonist binding in the human brain with [¹¹C]Cimbi-36.Ettrup A, da Cunha-Bang S, McMahon B, Lehel S, Dyssegaard A, Skibsted AW, Jørgensen LM, Hansen M, Baandrup AO, Bache S, Svarer C, Kristensen JL, Gillings N, Madsen J, Knudsen GM.Ettrup A, et al.J Cereb Blood Flow Metab. 2014 Jul;34(7):1188-96. doi: 10.1038/jcbfm.2014.68. Epub 2014 Apr 30.J Cereb Blood Flow Metab. 2014.PMID:24780897Free PMC article.Clinical Trial.
- Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain.Yang KC, Stepanov V, Martinsson S, Ettrup A, Takano A, Knudsen GM, Halldin C, Farde L, Finnema SJ.Yang KC, et al.Int J Neuropsychopharmacol. 2017 Sep 1;20(9):683-691. doi: 10.1093/ijnp/pyx051.Int J Neuropsychopharmacol. 2017.PMID:28911007Free PMC article.
- 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-[11C]methoxybenzyl)ethanamine.Leung K.Leung K.2011 Feb 18 [updated 2011 Mar 30]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.2011 Feb 18 [updated 2011 Mar 30]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.PMID:21473029Free Books & Documents.Review.
- 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-[11C]methoxybenzyl)ethanamine.Leung K.Leung K.2011 Jan 18 [updated 2011 Mar 23]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.2011 Jan 18 [updated 2011 Mar 23]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.PMID:21473027Free Books & Documents.Review.
Cited by
- Hunting for the high-affinity state of G-protein-coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imaging.Shalgunov V, van Waarde A, Booij J, Michel MC, Dierckx RAJO, Elsinga PH.Shalgunov V, et al.Med Res Rev. 2019 May;39(3):1014-1052. doi: 10.1002/med.21552. Epub 2018 Nov 18.Med Res Rev. 2019.PMID:30450619Free PMC article.Review.
- DARK Classics in Chemical Neuroscience: NBOMes.Poulie CBM, Jensen AA, Halberstadt AL, Kristensen JL.Poulie CBM, et al.ACS Chem Neurosci. 2020 Dec 2;11(23):3860-3869. doi: 10.1021/acschemneuro.9b00528. Epub 2019 Nov 12.ACS Chem Neurosci. 2020.PMID:31657895Free PMC article.Review.
- Human biodistribution and radiation dosimetry of the 5-HT2A receptor agonist Cimbi-36 labeled with carbon-11 in two positions.Johansen A, Holm S, Dall B, Keller S, Kristensen JL, Knudsen GM, Hansen HD.Johansen A, et al.EJNMMI Res. 2019 Jul 31;9(1):71. doi: 10.1186/s13550-019-0527-4.EJNMMI Res. 2019.PMID:31367837Free PMC article.
- Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?Colom M, Vidal B, Zimmer L.Colom M, et al.Front Mol Neurosci. 2019 Oct 18;12:255. doi: 10.3389/fnmol.2019.00255. eCollection 2019.Front Mol Neurosci. 2019.PMID:31680859Free PMC article.Review.
- Characterization of [11C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain.Yang KC, Stepanov V, Amini N, Martinsson S, Takano A, Nielsen J, Bundgaard C, Bang-Andersen B, Grimwood S, Halldin C, Farde L, Finnema SJ.Yang KC, et al.Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):308-320. doi: 10.1007/s00259-016-3544-9. Epub 2016 Nov 5.Eur J Nucl Med Mol Imaging. 2017.PMID:27817159Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources